Rosa De Vincenzo - Concepedia

Author

Rosa De Vincenzo

Università Cattolica del Sacro Cuore ORCID

Also Known As

R DEVINCENZO, R De Vincenzo, R P De Vincenzo, R. DE VINCENZO, R. De Vincenzo, R. P. De Vincenzo, R. de Vincenzo, Rosa DE VINCENZO, Rosa De Vincenzo, Rosa I. De Vincenzo

109

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Agostino Gemelli University Polyclinic Marche Polytechnic University Centro di Riferimento Oncologico Fondazione IRCCS Istituto Nazionale dei Tumori

About

Rosa De Vincenzo is an author at Università Cattolica del Sacro Cuore specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	1.7K
2	Public Health	10	10	320
3	Health Sciences	3	3	54
4	Natural Sciences	1	1	16
5	Biochemistry	1	1	16

Rosa De Vincenzo

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target Giovanni Scambia, Franco O. Ranelletti, P. Benedetti Panici, Cancer Chemotherapy and Pharmacology Breast OncologyMedicinePossible TargetBreast CancerPharmacotherapy	1994	272
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells Giovanni Scambia, FO Ranelletti, Pierluigi Benedetti Panici, British Journal of Cancer Primary Ovarian TumoursMedicineHormonal ReceptorOvca 433Gynecology	1990	130
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites Giovanni Scambia, F O Ranelletti, P. Benedetti Panici, Cancer Chemotherapy and Pharmacology Breast OncologyMedicineBreast CancerAnti-cancer AgentPharmacology	1991	122
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study Giorgio Bogani, Violante Di Donato, Francesco Sopracordevole, Gynecologic Oncology Laser Conization5-Year Follow-up StudyRecurrence RateOphthalmologyOculoplastics	2020	107
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin Giovanni Scambia, Rosa De Vincenzo, P.O. Ranelletti, European Journal of Cancer Antiproliferative EffectMalignant DiseaseMedicinePathologyAnti-cancer Agent	1996	101
Significance of epidermal growth factor receptor in advanced ovarian cancer. Giovanni Scambia, P. Benedetti Panici, Federica Battaglia, Journal of Clinical Oncology	1992	94
In vitro evaluation of newly developed chalcone analogues in human cancer cells Rosa De Vincenzo, Cristiano Ferlini, Mariagrazia Distefano, Cancer Chemotherapy and Pharmacology OncologyMedicineTumor TargetingChalcone AnaloguesAnti-cancer Agent	2000	93
EGF receptor expression in primary laryngeal cancer: Correlation with clinico‐pathological features and prognostic significance Maurizio Maurizi, Giovanni Scambia, Pierluigi Benedetti Panici, International Journal of Cancer	1992	85
Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix Paola Cattani, Gian Franco Zannoni, Caterina Ricci, Journal of Clinical Microbiology PathologyGynecologyCytopathologyHigh-grade LesionsHuman Papillomavirus E6	2009	80
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II) Giovanni Scambia, Franco O. Ranelletti, P. Benedetti Panici, Gynecologic Oncology Synergistic ActivityMedicinal ChemistryHormonal ContraceptiveMedicineGynecology	1992	78

Page 1